genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Myriad Genetics
News
Insights
Industry News
Myriad Genetics, VA to Assess Genetic Test for Major Depressive Disorder
News
Insights
Industry News
Myriad to Acquire Assurex Health for Up to $410M
Industry News
Myriad Acquires Sividon Diagnostics for Up to $56M
News
Australia’s Top Court Joins U.S. in Closing Door on Gene Patentability
Insights
Patent Protection on Biotechnology Inventions after Myriad
News
Myriad, AbbVie Expand Tumor BRACAnalysis CDx Collaboration
A-Lists
Top 14 Molecular Diagnostics Firms
Cancer
Tesaro to Use Myriad’s HRD Test in Companion Dx Collab
1
2
3
...
7
Page 1 of 7
Scroll Up
Scroll Up
